ESTEVE CDMO Commits Additional $17.5M to Expand U.S. Manufacturing Capacity

URLhttps://drug-dev.com/esteve-cdmo-commits-additiona
SourceCaptisol
Date Published09/01/2026

Additional Reshoring Information:

Company/Division name ESTEVE CDMO
Parent companyESTEVE CDMO
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2026
Domestically, the work will be done:In-house
Capital investment ($):17.5
Country(ies) from which reshored:Spain
City reshored to:Morton Grove
State(s) reshored to:IL
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpharmaceuticals
Find Reshoring Articles